案例研究代写：人工耳蜗的股价
如果不考虑财务信息，人工耳蜗的股价增长可以归因于三个主要原因。首先，所生产的技术和设备在市场上赢得了良好的声誉。案例研究表明，人工耳蜗是一种成功的耳蜗植入装置。对于许多听力受损的人来说，这是一个解决方案。这家公司参与了这项成功的技术，因此随着对其产品的需求和产品的受欢迎程度的提高，其股价也随之上涨。其次，耳蜗不是一个独立的机构。该公司前身是普太邓洛普(Pacific Dunlop)旗下的核心有限公司(Nucleus Ltd)的一个业务部门。耳蜗因此有了这些公司的商业专业知识的支持。此外，利用这些专业知识，公司得以将主要业务扩展到大洋洲和欧洲等地。最后，耳蜗作为一个学习型组织，与研究人员和其他研究机构合作，为他们保留了部分股份。这将再次推动产品开发，并促进股价上涨。
案例研究代写：人工耳蜗的股价
每股收益的增加被认为是推动股价上涨的因素，股价从0.217升至0.602(从1996年到2001年)，股价从3.870升至39.000。每股收益($)的趋势是一致的。在每股现金流($)的情况下，观察到股价($)上涨的不一致趋势。
案例研究代写：人工耳蜗的股价
Without taking financial information into consideration, Cochlear’s share price growth could be attributed to three main reasons. Firstly, the technology and device being produced has earned a good reputation in the market. The case study shows that the cochlear implant was a successful ear implant device. It was a solution for many who suffered hearing impairment. The company was involved with this success technology and hence it share-price increased, as demand for its products, and popularity of products increased. Secondly, Cochlear was not a standalone institution. It sprung from a former business segment of Nucleus Ltd, which was a subsidiary of Pacific Dunlop. Cochlear hence had the business expertise backup of these companies to rely on. Furthermore, using such expertise, the company was able to spread its main operations across Australasia and Europe etc. Finally, Cochlear stayed as a learning organization, and worked with researchers and other research institutes, reserving some of its shares for them. This once again would have driven the product development and contributed to share price growth.
案例研究代写：人工耳蜗的股价
An increase in earnings per share is seen to drive share price, as values 0.217 to 0.602 (from 1996 to 2001) increases, the share prices are driven from 3.870 to 39.000. A consistent trend is observed in the case of Earnings per share ($). An inconsistent trend with respect to share price ($) increase is observed in the case of Cash flow per share ($).
